| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 155.828 | 127.946 | 150.383 | 170.772 | 161.547 | 127.066 | 144.048 | 149.416 | 180.995 | 199.495 |
| Total Income - EUR | 160.729 | 131.135 | 151.653 | 172.327 | 161.898 | 130.892 | 145.038 | 149.518 | 182.138 | 200.384 |
| Total Expenses - EUR | 101.896 | 80.685 | 91.916 | 97.466 | 90.767 | 74.220 | 86.850 | 95.733 | 100.501 | 106.788 |
| Gross Profit/Loss - EUR | 58.834 | 50.450 | 59.737 | 74.861 | 71.131 | 56.672 | 58.188 | 53.785 | 81.637 | 93.595 |
| Net Profit/Loss - EUR | 49.783 | 42.822 | 57.788 | 73.138 | 69.512 | 55.389 | 56.738 | 52.290 | 79.816 | 88.739 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Medoptic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.999 | 10.915 | 29.747 | 26.545 | 22.759 | 21.743 | 17.967 | 15.522 | 12.186 | 18.086 |
| Current Assets | 74.076 | 62.195 | 86.440 | 90.310 | 78.452 | 64.202 | 73.075 | 70.153 | 97.059 | 153.500 |
| Inventories | 12.327 | 14.329 | 15.327 | 12.710 | 9.751 | 7.549 | 8.977 | 13.628 | 12.094 | 13.609 |
| Receivables | 1.247 | 2.039 | 5.441 | 277 | 272 | 34.896 | 32.338 | 21.475 | 30.324 | 90.330 |
| Cash | 60.502 | 45.827 | 65.672 | 77.322 | 68.430 | 21.756 | 31.760 | 35.050 | 54.641 | 49.561 |
| Shareholders Funds | 74.556 | 67.342 | 81.893 | 96.801 | 92.717 | 78.153 | 78.998 | 74.618 | 102.107 | 110.906 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.519 | 5.768 | 34.294 | 20.055 | 8.494 | 7.791 | 12.043 | 11.057 | 7.138 | 60.680 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medoptic Srl